TABLE 2.
Average Annual Rate of Decline in UPDRS Scores in the DATATOP Study.
| Treatment | Total UPDRS |
|---|---|
| Placebo | 14.02 ± 12.32 |
| Tocopherol | 15.16 ± 16.12 |
| Selegiline | 7.00 ± 10.76 |
| Tocopherol and selegiline | 7.28 ± 11.11 |
| p Value between the selegiline groups and the placebo/tocopherol groups | <0.001 |
Results are expressed as mean ± SD. From Parkinson Study Group, 1993.119